{
    "clinical_study": {
        "@rank": "137990", 
        "acronym": "J-FIRST", 
        "arm_group": {
            "arm_group_label": "Parkinson Disease"
        }, 
        "brief_summary": {
            "textblock": "This study is implemented to identify factors having an impact on improvement or\n      exacerbation of non-motor symptoms, to provide information contributing to development of\n      medical care in this field and improvement of patients' QOL, and to clarify the association\n      between the use of istradefylline and non-motor symptoms or QOL."
        }, 
        "brief_title": "Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients", 
        "condition": "Parkinson Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who have wearing off under treatment with levodopa-containing drugs\n             administered at least three times daily\n\n          -  Patients who have at least one non-motor symptom as a complication\n\n          -  Patients at least 20 years of age at the time of consent\n\n          -  Patients who have given written consent\n\n          -  Patients who are receiving outpatient care\n\n        Exclusion Criteria:\n\n          -  Patients with dementia or a score of 23 or less on the Mini-Mental State Examination\n             (MMSE)\n\n          -  Patients, in the opinion of the investigator or subinvestigator, having conditions\n             impairing the proper assessment of the MDS-UPDRS or PDQ-8 (e.g., patients who are\n             receiving treatment for malignant tumor)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Parkinson Disease"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073981", 
            "org_study_id": "J-FIRST"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Parkinson Disease", 
        "lastchanged_date": "April 23, 2014", 
        "location": {
            "contact": {
                "email": "clinical.info@kyowa-kirin.co.jp", 
                "last_name": "Kyowa Hakko Kirin Company, Limited"
            }, 
            "facility": {
                "address": {
                    "city": "Bunkyo-ku", 
                    "country": "Japan", 
                    "state": "Tokyo", 
                    "zip": "113-8431"
                }, 
                "name": "Juntendo University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Japan-First-in Large Scale Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients.", 
        "overall_contact": {
            "email": "clinical.info@kyowa-kirin.co.jp", 
            "last_name": "Kyowa Hakko Kirin Company, Limited"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Japan: Ministry of Health, Labor and Welfare", 
                "Japan: Ministry of Education, Culture, Sports, Science and Technology"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "MDS-UPDRS score will be collected from all registrant at each visit and on the last day of survey.", 
                "measure": "Changing of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "PDQ-8 score will be collected from all registrant at each visit and on the last day of survey.", 
                "measure": "Changing of Parkinson's Disease Questionaire-8 (PDQ-8) score.", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073981"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Kyowa Hakko Kirin Company, Limited", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kyowa Hakko Kirin Company, Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}